Is it possible to prevent pediatric diseases?

pediatric diseases

The first questions of families affected by pediatric diseases are…

“Why me?”

“Why my child?”

“What could I have done to avoid this?”

“What can I do to be cured or to get better?”

Patients faced with a genetic disease are asking clinicians what could have done to prevent the disease, especially with pediatric diseases. Frequently there is a known underlying reason for a disorder afflicting a family, but sometimes genetic diseases can appear without any prior family history. The knowledge of a specific disease-causative mutation(s) allows not only better disease prognosis but also allows families to ensure that the next generation of kids will be free of disease.

Single-gene disorders, while individually rare, but with more than 3000 Mendelian disorders, for half of which disease gene has not yet been uncovered, genetic disorders and pediatric diseases enthrallan enormous impact on the well-being of over 500,000 children in Canada.

How genetic testing can identify pediatric diseases

Genetic testing of prospective parents,in conjunction with pre-implantation genetic diagnostics (PDG), can save life long suffering from a genetic disease, but only if there is a clear understanding of disease susceptibility. Knowing an individuals genomic profile allows us to better prepare or to avoid the negative impacts they might have on health and lifespan of the individual an his/her descendants.

Until recently we did not know how to identify rapidly the underlying mutations within our genome. Genetic technologies have developed at neck braking speed creating a huge gap in understanding of the benefits and limitations of these technologies for general population as well as the majority of medical professionals. In the short years since the first Next Generation Sequencing (NGS) became available it has dramatically accelerated multiple areas of genomics research, uncovering genetic defects underlying inherited disorders.

Today, the number of known disease causing mutations now exceeds 100,000 in more than 3700 different genes. However, this figure represents only a small fraction of the clinically relevant genetic variants in the human genome – recent studies have estimated that about 40% of disease-causing mutations are so rare that they occur only in one family.

What disorders can genetic testing discover?

NGS, and specifically exome sequencing, brings new ways of assessing genetic disorders: protein-coding genes constitute only approximately 1% of the human genome but harbor about 85% of the disease-causing mutations that are evident in pediatric diseases. Therefore, exome analysis allows capturing most Mendelian disorders that are caused by “coding mutations” or splice-site mutations.

Several initiatives such as the Canadian Pediatric Genetic Disorders Sequencing (CPGDS) Consortium that evolved in to larger finding of Rare Disease Genes (FORGE Canada), and Rare Disease Consortium for Autosomal Loci (RaDiCAL) aim to characterize Mendelian disorders through exome sequencing.

This technology already has lead to remarkable life-saving discoveries: Nicholas Volker is the first boy saved by sequencing technology. Since birth he was afflicted with “masterious” severe inflammatory bowel disease due to a mutation inXIAP – one of immune response genes, so doctors figured our that a bone morrow transplant will cure his disease. Another remarkable example of genetic testing helping with pediatric diseases is Shelby’s story who was a severely disabled by an autism-like disorder to ditch a wheelchair after scientists were able to find appropriate medication based on her genetic profile.

Our current challenge is the ability to identify handful of potentially pathogenic mutations among the many thousands of new variants detected in each individual. New bioinformatics analysis tools and the availability and rapidly decreasing cost exome sequencing offer new opportunities for developing genetic disease prevention strategies.

Pioneering work is being done at Children’s Mercy Hospitals and Clinics in Kansas City where physicians sequenced genomes of 40 sick babies in the Neonatal Intensive Care Unit within 50 hours. “Up to one third of babies admitted to a NICU in the U.S. have genetic diseases,” said Stephen Kingsmore, M.B. Ch.B., D.Sc., FRCPath, Director of the Center for Pediatric Genomic Medicine at Children’s Mercy. “By obtaining an interpreted genome in about two days, physicians can make practical use of diagnostic results to tailor treatments to individual infants and children.”

The future of exome sequencing

Ironically, the power of exome sequencing is not yet harnessed for analysis of fertility and family planning. Understanding of inherited genetic risks helps to avoid many preventable tragedies such as children’s death due to heart failure as majority of these conditions are congenital – i.e. have underlying genetic cause.

Family is the essential unit of health from multiple perspective and members share the same environmental risk factors such as dietary habits, as well as emotional and genetic connections that together impact on happiness and longevity. Therefore, we advocate proactive family planning starting with genetic analysis of prospective parents.

What’s next?

If you would like to learn more about genetic testing and fertility, continue reading this related blog post: “Fertility Problems in Women: When to Ask for Treatment”.

If you enjoyed this post and want to read more, please follow us on Twitter or become a fan on Facebook.

Try now

Join our newsletter

  • Stay connected to insightful articles and blog posts
  • Stay in the loop with the latest news
  • Receive special offers on GeneYouIn products!


Please select areas of interest:
 Drug response
 Inherited disease predisposition
 Fertility
 Cancer
 Mental Health
 Healthy Living

GeneYouIn Inc. © 2012-2017. All rights reserved